Lebwohl MG, Merola JF, Rowland K, Miller M, et al. Safety of Guselkumab Treatment for up to 5 Years in Patients With Moderate-to-Severe Psoriasis: Pooled Analyses Across Seven Clinical Trials With Greater Than 8600 Patient-Years of Exposure. Br J Dermatol 2023 Apr 6:ljad115. doi: 10.1093.
PMID: 37022762